GlassScriptPhysician profile
Slif Ulrich
NPI 1447413851
$12,261.41
in general payments reported to CMS, 2019-2025
13 companies · $898 in 2025
The $898 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,067 · 2020: $464 · 2021: $3,461 · 2022: $822 · 2023: $3,280 · 2024: $1,270 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,360 · Travel and Lodging: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,359.56 |
| Travel and Lodging | $1,088.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,869.56 | 2021-2025 | Polarstem, Journey, Ri Hip Navigation |
| Zimmer Biomet Holdings, INC. | $3,630.21 | 2019-2025 | Rosa, Persona, Avenir |
| Stryker Corporation | $3,388.54 | 2019-2025 | Mako, Insignia, Triathlon |
| Medacta USA, INC. | $411.89 | 2024-2025 | Mecta |
| Horizon Therapeutics Plc | $260.46 | 2019-2020 | |
| Osteoremedies, LLC | $237.17 | 2019 | |
| Acera Surgical, INC. | $153.60 | 2025 | Restrata Wound Matrix |
| Sanara Medtech INC. | $138.73 | 2022-2025 | Celleraterx |
| Depuy Synthes Sales INC. | $101.46 | 2021-2023 | Va-Lcp, Na, Fibulink |
| Innovation Technologies INC | $23.58 | 2022 | |
| Kci USA, INC. | $16.39 | 2023 | V.A.C. Dermatac |
| Convatec INC. | $16.22 | 2021 | |
| Heron Therapeutics, INC. | $13.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Slif Ulrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.